Paul E. Fleming,Geraldine C. B. Harriman,Zhan Shi,B. Shaowu Chen
申请号：
US14049452
公开号：
US09035096B2
申请日:
2013.10.09
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to compounds represented by Structural Formula I, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use compounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.
